Evans John M. (CIK 1786304) reported 25 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-01). Recent activity: Buy BEAM (18,663 shares), Buy BEAM (6,337 shares), Sell BEAM (13,421 shares), Sell BEAM (11,579 shares), Buy BEAM (25,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | Beam Therapeutics Inc. (BEAM) | CEO | Buy | 18,663 | $12,504 |
| 2026-07-01 | Beam Therapeutics Inc. (BEAM) | CEO | Buy | 6,337 | $6,527 |
| 2026-07-01 | Beam Therapeutics Inc. (BEAM) | CEO | Sell | 13,421 | $471,528 |
| 2026-07-01 | Beam Therapeutics Inc. (BEAM) | CEO | Sell | 11,579 | $415,824 |
| 2026-07-01 | Beam Therapeutics Inc. (BEAM) | CEO | Buy | 25,000 | $25,750 |
| 2026-07-01 | Beam Therapeutics Inc. (BEAM) | CEO | Sell | 23,100 | $791,482 |
| 2026-07-01 | Beam Therapeutics Inc. (BEAM) | CEO | Sell | 1,900 | $66,203 |
| 2026-04-06 | Beam Therapeutics Inc. (BEAM) | CEO | Sell | 30,078 | $739,317 |
| 2026-04-01 | Beam Therapeutics Inc. (BEAM) | CEO | Buy | 90,000 | $0 |
| 2026-04-01 | Beam Therapeutics Inc. (BEAM) | CEO | Sell | 25,000 | $559,250 |
| 2026-04-01 | Beam Therapeutics Inc. (BEAM) | CEO | Buy | 25,000 | $16,750 |
| 2026-04-01 | Beam Therapeutics Inc. (BEAM) | CEO | Sell | 25,000 | $569,000 |
| 2026-04-01 | Beam Therapeutics Inc. (BEAM) | CEO | Buy | 25,000 | $16,750 |
| 2026-02-02 | Beam Therapeutics Inc. (BEAM) | CEO | Buy | 19,336 | $12,955 |
| 2026-02-02 | Beam Therapeutics Inc. (BEAM) | CEO | Buy | 5,664 | $3,795 |
| 2026-02-02 | Beam Therapeutics Inc. (BEAM) | CEO | Sell | 16,333 | $476,760 |
| 2026-02-02 | Beam Therapeutics Inc. (BEAM) | CEO | Sell | 8,667 | $257,757 |
| 2026-02-02 | Beam Therapeutics Inc. (BEAM) | CEO | Buy | 25,000 | $16,750 |
| 2026-02-02 | Beam Therapeutics Inc. (BEAM) | CEO | Sell | 22,094 | $624,597 |
| 2026-02-02 | Beam Therapeutics Inc. (BEAM) | CEO | Sell | 2,906 | $84,274 |
| 2025-10-03 | Beam Therapeutics Inc. (BEAM) | CEO | Buy | 25,000 | $16,750 |
| 2025-10-03 | Beam Therapeutics Inc. (BEAM) | CEO | Sell | 25,000 | $612,750 |
| 2025-10-03 | Beam Therapeutics Inc. (BEAM) | CEO | Buy | 25,000 | $16,750 |
| 2025-10-03 | Beam Therapeutics Inc. (BEAM) | CEO | Sell | 25,000 | $615,750 |
| 2025-04-03 | Beam Therapeutics Inc. (BEAM) | CEO | Sell | 30,663 | $562,666 |
来源：SEC Form 4 申报文件 · 截至 2026-07-01